S 2477
116th Congress
Senate
Health
Advisory bodies
Congressional oversight
Government studies and investigations
Health programs administration and funding
Health promotion and preventive care
Medical research
Medical tests and diagnostic methods
Musculoskeletal and skin diseases
Organ and tissue donation and transplantation
Research administration and funding
Research and development
National Commission on Scleroderma and Fibrotic Diseases Act of 2019
Introduced: September 12, 2019
Introduced by:
Gillibrand, Kirsten E.
Democratic
· New York
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 12, 2019
Introduced in Senate
Plain-English summary
National Commission on Scleroderma and Fibrotic Diseases Act of 2019
This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1